CTSO May 2024 2.500 put
| Previous close | 1.9000 |
| Open | 0.9600 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 2.50 |
| Expiry date | 2024-05-17 |
| Day's range | 0.9600 - 1.9000 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
Simply Wall St.Cytosorbents First Quarter 2024 Earnings: In Line With Expectations
Cytosorbents ( NASDAQ:CTSO ) First Quarter 2024 Results Key Financial Results Revenue: US$9.79m (up 3.6% from 1Q 2023...
Insider MonkeyCytosorbents Corporation (NASDAQ:CTSO) Q1 2024 Earnings Call Transcript
Cytosorbents Corporation (NASDAQ:CTSO) Q1 2024 Earnings Call Transcript May 9, 2024 Cytosorbents Corporation beats earnings expectations. Reported EPS is $-0.11717, expectations were $-0.12. Cytosorbents Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon and welcome to CytoSorbents’ First […]
GlobeNewswireCytoSorbents Reports First Quarter 2024 Results
Product Sales up a robust 14% over prior year, and a significant 22% sequentiallyWe believe the STAR-T data presented at AATS support a favorable benefit-to-risk profile of DrugSorb-ATR in coronary artery bypass graft (CABG) patients On track for U.S. Food and Drug Administration (FDA) De Novo and Health Canada submissions for DrugSorb®-ATR in Q3 2024 PRINCETON, N.J., May 09, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a pioneer in critical care and cardiac surgery blood pu
